| Tert-butyl 3-[(2S,5S,8S)-14-methoxy-2-(2-methylpropyl)-4,7-dioxo-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraen-5-yl]propanoate | IC50 | 227.0 [1] |
| Fumitremorgin C | IC50 | 731.0 [1] |
| Fumitremorgin C | Ki | 1300.0 [1] |
| Tariquidar | IC50 | 850.0 [1] |
| N-[2-[[4-[2-(3,4-Dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]phenyl]quinoline-3-carboxamide | IC50 | 721.0 [1] |
| Elacridar | IC50 | 250.0 [1] |
| Imatinib | IC50 | 500.0 [1], 900.0 [2], 3380.0 [3], 4070.0 [4], 4897.79 [5] |
| 4-Methoxy-N-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 199.0 [1], 300.0 [2], 492.0 [3], 505.0 [4], 746.0 [5] |
| Gefitinib | IC50 | 400.0 [1], 1100.0 [2], 1260.0 [3], 3190.0 [4] |
| Novobiocin | IC50 | 25000.0 [1], 66069.34 [2], 85100.0 [3], 104000.0 [4] |
| Retusin | IC50 | 390.0 [1], 540.0 [2], 570.0 [3], 900.0 [4] |
| N,2-Diphenylquinazolin-4-amine | IC50 | 882.0 [1], 2570.0 [2] |
| N-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-4-nitrobenzamide | IC50 | 78.9 [1], 307.0 [2], 387.0 [3], 585.0 [4] |
| N-[2-[2-(4-Methoxyphenyl)tetrazol-5-yl]phenyl]-4-nitrobenzamide | IC50 | 118.0 [1], 378.0 [2], 535.0 [3], 587.0 [4] |
| 2-(3,4-Dimethoxyphenyl)-N-(4-nitrophenyl)quinazolin-4-amine | IC50 | 43.65 [1], 300.0 [2], 320.0 [3], 2960.0 [4] |
| 2-(3,4-Dimethoxyphenyl)-N-(3-nitrophenyl)quinazolin-4-amine | IC50 | 76.0 [1], 81.28 [2], 92.0 [3], 19400.0 [4] |
| 2-[(4-Nitrobenzoyl)amino]-N-(4-propylphenyl)benzamide | IC50 | 594.0 [1], 783.0 [2], 833.0 [3], 940.0 [4] |
| Ayanin | IC50 | 460.0 [1], 680.0 [2], 5700.0 [3] |
| (E)-1,3-Bis(3,4-dimethoxyphenyl)prop-2-en-1-one | IC50 | 3280.0 [1], 3800.0 [2], 5120.0 [3] |
| N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]phenyl]-3,4-dimethoxybenzamide | IC50 | 860.0 [1], 930.0 [2], 2089.3 [3] |
| 2-Amino-N-(4-(2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)benzamide | IC50 | 17800.0 [1], 20900.0 [2], 74131.02 [3] |
| N-(4-(2-(3,4-Dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2-nitrobenzamide | IC50 | 45700.0 [1], 51300.0 [2], 79432.82 [3] |
| N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2-nitrobenzamide | IC50 | 40000.0 [1], 77600.0 [2], 109647.82 [3] |
| 2-Amino-N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)benzamide | IC50 | 20700.0 [1], 32400.0 [2], 85113.8 [3] |
| 4-Amino-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]benzamide | IC50 | 98200.0 [1], 219000.0 [2], 263026.8 [3] |
| N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-nitrobenzamide | IC50 | 4380.0 [1], 6920.0 [2], 7585.78 [3] |
| N-[2-(2-Phenyltetrazol-5-yl)phenyl]benzamide | IC50 | 64.0 [1], 66.9 [2] |
| N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-oxo-5-phenylmethoxychromene-2-carboxamide | IC50 | 170.0 [1], 1800.0 [2] |
| 3-[[2-(3,4-Dimethoxyphenyl)quinazolin-4-yl]amino]benzonitrile | IC50 | 136.0 [1], 190.0 [2], 300.0 [3] |
| 4-Azido-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 1267.0 [1], 1501.0 [2], 1615.0 [3] |
| N-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-2-nitrobenzamide | IC50 | 1100.0 [1], 1320.0 [2], 1880.0 [3] |
| 1-[2-[2-(4-Methoxyphenyl)tetrazol-5-yl]phenyl]-3-(4-nitrophenyl)urea | IC50 | 331.0 [1], 541.0 [2], 718.0 [3] |
| 2-[(4-Nitrophenyl)carbamoylamino]-N-[4-(trifluoromethyl)phenyl]benzamide | IC50 | 452.0 [1], 605.0 [2], 711.0 [3] |
| 1-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-3-(2-nitrophenyl)urea | IC50 | 882.0 [1], 978.0 [2], 1172.0 [3] |
| 4-Isothiocyanato-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 952.0 [1], 1050.0 [2], 1221.0 [3] |
| 4-[(2-Bromoacetyl)amino]-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 283.0 [1], 446.0 [2], 605.0 [3] |
| 2-[(4-Methoxybenzoyl)amino]-N-(4-propylphenyl)benzamide | IC50 | 1656.0 [1], 2012.0 [2], 2526.0 [3] |
| 1-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-3-(4-nitrophenyl)urea | IC50 | 403.0 [1], 544.0 [2], 832.0 [3] |
| 2-[(2-Nitrophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide | IC50 | 1120.0 [1], 2563.0 [2], 3662.0 [3] |
| 1-(4-Aminophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea | IC50 | 379.0 [1], 571.0 [2], 838.0 [3] |
| 1-(4-Methoxyphenyl)-3-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]urea | IC50 | 355.0 [1], 382.0 [2], 442.0 [3] |
| 2-[(4-Nitrophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide | IC50 | 325.0 [1], 482.0 [2], 622.0 [3] |
| 4-Acetamido-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 1202.0 [1], 1325.0 [2], 1363.0 [3] |
| 1-(4-Isothiocyanatophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea | IC50 | 550.0 [1], 667.0 [2], 1515.0 [3] |
| 2-[(3-Nitrobenzoyl)amino]-N-(4-propylphenyl)benzamide | IC50 | 512.0 [1], 727.0 [2], 785.0 [3] |
| 2-[(2-Nitrobenzoyl)amino]-N-(3-propylphenyl)benzamide | IC50 | 1713.0 [1], 2151.0 [2], 2814.0 [3] |
| 4-Amino-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide | IC50 | 299.0 [1], 491.0 [2], 549.0 [3] |
| 2-Bromo-N-[4-[[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]carbamoylamino]phenyl]acetamide | IC50 | 472.0 [1], 583.0 [2], 798.0 [3] |
| 2-[(4-Methoxyphenyl)carbamoylamino]-N-(4-propylphenyl)benzamide | IC50 | 985.0 [1], 2173.0 [2], 3371.0 [3] |
| 2-[(3-Nitrophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide | IC50 | 348.0 [1], 501.0 [2], 651.0 [3] |
| N-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-4-propylbenzamide | IC50 | 131.0 [1], 207.0 [2], 354.0 [3] |
| N-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-3-nitrobenzamide | IC50 | 866.0 [1], 1390.0 [2], 1801.0 [3] |
| 1-(4-Azidophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea | IC50 | 685.0 [1], 691.0 [2], 913.0 [3] |
| N-[4-[[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]carbamoylamino]phenyl]acetamide | IC50 | 325.0 [1], 454.0 [2], 627.0 [3] |
| 1-[2-[2-(3-Methoxyphenyl)tetrazol-5-yl]phenyl]-3-(3-nitrophenyl)urea | IC50 | 750.0 [1], 807.0 [2], 967.0 [3] |
| 2-[(4-Bromophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide | IC50 | 952.0 [1], 2121.0 [2], 2655.0 [3] |
| Cyclosporin A | IC50 | 63095.73 [1] |
| Cyclosporin A | Ki | 500.0 [1] |
| Verapamil | IC50 | 50000.0 [1], 524807.46 [2] |
| Quercetin | IC50 | 6900.0 [1], 7600.0 [2] |
| Reserpine | IC50 | 12600.0 [1], 26302.68 [2] |
| Estrone | IC50 | 3000.0 [1], 10000.0 [2] |
| Genistein | IC50 | 6900.0 [1], 8800.0 [2] |
| Diethylstilbestrol | IC50 | 500.0 [1] |
| Apigenin | IC50 | 3100.0 [1], 5900.0 [2] |
| Kaempferol | IC50 | 4700.0 [1], 6200.0 [2] |
| beta-Naphthoflavone | IC50 | 6050.0 [1], 8320.0 [2] |
| Flavone | IC50 | 17000.0 [1], 26000.0 [2] |
| Morin | IC50 | 21000.0 [1], 49000.0 [2] |
| Chrysin | IC50 | 1500.0 [1], 2600.0 [2] |
| alpha-Naphthoflavone | IC50 | 1310.0 [1], 1400.0 [2] |
| Dolutegravir | IC50 | 30000.0 [1], 67000.0 [2] |
| Nobiletin | IC50 | 4400.0 [1], 4900.0 [2] |
| N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 1730.0 [1], 2320.0 [2] |
| Tangeretin | IC50 | 17000.0 [1], 19000.0 [2] |
| 5,7-Dimethoxyflavone | IC50 | 9200.0 [1], 11000.0 [2] |
| Sinensetin | IC50 | 8300.0 [1], 9000.0 [2] |
| (S)-2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4-benzopyrone | IC50 | 8900.0 [1], 31000.0 [2] |
| 3,3',4',5,6,7,8-Heptamethoxyflavone | IC50 | 1400.0 [1], 1600.0 [2] |
| Diethylstilbestrol dipropionate | IC50 | 3000.0 [1] |
| 2'-Hydroxy-4,4',6'-trimethoxychalcone | IC50 | 3000.0 [1], 5830.0 [2] |
| 6-Methoxyflavone | IC50 | 3400.0 [1], 10000.0 [2] |
| Quercetin pentamethyl ether | IC50 | 822.0 [1], 1880.0 [2] |
| 3-Methoxyflavone | IC50 | 1210.0 [1], 1280.0 [2] |
| Megalip | IC50 | 1910.0 [1], 2340.0 [2] |
| Penduletin | IC50 | 1200.0 [1], 2000.0 [2] |
| 6-Methoxyflavanone | IC50 | 19000.0 [1], 46000.0 [2] |
| 1-(2-Hydroxy-4-methoxyphenyl)-3-(4-methoxyphenyl)-2-propen-1-one | IC50 | 2200.0 [1], 4200.0 [2] |
| 2',4'-Dihydroxy-4-methoxychalcone | IC50 | 12050.0 [1], 33320.0 [2] |
| 2'-Hydroxy-4'-Methoxychalcone | IC50 | 30950.0 [1], 31020.0 [2] |
| 5,7-Dimethoxyflavanone | IC50 | 17000.0 [1], 32000.0 [2] |
| 3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one | IC50 | 1060.0 [1], 2170.0 [2] |
| 3',4'-Dimethoxy-alpha-naphthoflavone | IC50 | 1130.0 [1], 1230.0 [2] |
| 2',4'-Dihydroxy-4-chlorochalcone | IC50 | 6070.0 [1], 6370.0 [2] |
| (E)-3-(4-Chlorophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one | IC50 | 10720.0 [1], 13510.0 [2] |
| N-[3-(Trifluoromethyl)phenyl]-4-quinazolinamine | IC50 | 940.0 [1], 1550.0 [2] |
| N-(3-Bromophenyl)quinazolin-4-amine | IC50 | 1080.0 [1], 1480.0 [2] |
| 2-(3,4-Dimethoxyphenyl)-3-hydroxy-7-methoxy-4H-chromen-4-one | IC50 | 1010.0 [1], 1770.0 [2] |
| 6,7-Dimethoxy-N-(3-(trifluoromethyl)phenyl)quinazolin-4-amine | IC50 | 1980.0 [1], 2400.0 [2] |
| 2-Chloro-4',6'-dimethoxy-2'-hydroxychalcone | IC50 | 2820.0 [1], 5270.0 [2] |